NEXUMED
ActiveFinancials · financial year 2025, abbreviated format
Annual accounts 2025 filed on 27-04-2026 PDF all 3 filings
Every figure per financial year
The operating result for 2025 is 3.2 times that of 2024 and the highest since 2023. It is the second rise in a row.
Turnover and EBIT margin are not published. The abbreviated format does not require them. The turnover shown is an estimate from the gross margin.
Staff
| Item | 31-12-2024 | 31-12-2025 |
|---|---|---|
| Employees at the balance-sheet date | 1 | 1 |
| full-time | 1 | 1 |
| in full-time equivalents | 1 | 1 |
| Average over the year, in full-time equivalents | 1 | 1 |
| On a permanent contract | 1 | 1 |
| Joined | 1 | - |
| Left | 0 | - |
Source: social balance sheet in the 2024 to 2025 annual accounts
Investments
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Intangible fixed assets | €28,880 | €20,250 | €101,974 |
| Depreciation and write-downs of the year | €1,108 | €5,787 | €13,618 |
Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)
Subsidies and aid
Flemish government
2023 · 1 entry · €371 awarded · €371 paid| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | €3,967 | €51,120 | ▲ 13× |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1,108 | €5,787 | €13,618 | ▲ 135% |
| Other operating charges640/8 | €141 | €108 | €62 | ▼ 42.6% |
| Gross operating margin9900 | -€9,757 | €16,989 | €87,630 | ▲ 416% |
| Operating profit (loss)9901 | -€11,005 | €7,127 | €22,830 | ▲ 220% |
| Financial income75/76B | - | - | €2 | - |
| Recurring financial income75 | - | - | €2 | - |
| Financial charges65/66B | €37 | €51 | €49 | ▼ 3.8% |
| Recurring financial charges65 | €37 | €51 | €49 | ▼ 3.8% |
| Profit (loss) for the period before taxes9903 | -€11,042 | €7,076 | €22,783 | ▲ 222% |
| Income taxes67/77 | - | €11 | €132 | ▲ 12× |
| Profit (loss) for the period9904 | -€11,042 | €7,065 | €22,651 | ▲ 221% |
| Profit (loss) for the period to be appropriated9905 | -€11,042 | €7,065 | €22,651 | ▲ 221% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €44,392 | €76,265 | €237,335 | ▲ 211% |
| Fixed assets21/28 | €27,772 | €42,235 | €130,591 | ▲ 209% |
| Intangible fixed assets21 | €27,772 | €42,235 | €130,591 | ▲ 209% |
| Current assets29/58 | €16,620 | €34,030 | €106,743 | ▲ 214% |
| Amounts receivable within one year40/41 | €6,456 | €20,720 | €102,173 | ▲ 393% |
| Trade receivables40 | - | €20,262 | €101,974 | ▲ 403% |
| Other amounts receivable41 | €6,456 | €458 | €199 | ▼ 56.6% |
| Cash at bank and in hand54/58 | €10,164 | €11,563 | €4,570 | ▼ 60.5% |
| Deferred charges and accrued income490/1 | - | €1,747 | - | - |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €44,392 | €76,265 | €237,335 | ▲ 211% |
| Equity10/15 | -€10,042 | -€2,976 | €19,674 | - |
| Contributions10/11 | €1,000 | €1,000 | €1,000 | = |
| Reserves13 | - | - | €18,674 | - |
| Distributable reserves133 | - | - | €18,674 | - |
| Profit (loss) carried forward14 | -€11,042 | -€3,976 | - | - |
| Amounts payable17/49 | €54,434 | €79,242 | €217,660 | ▲ 175% |
| Amounts payable after more than one year17 | €54,000 | €50,000 | €70,300 | ▲ 40.6% |
| Financial debts170/4 | €54,000 | €50,000 | €70,300 | ▲ 40.6% |
| Amounts payable within one year42/48 | €434 | €29,242 | €147,360 | ▲ 404% |
| Trade debts44 | €118 | €21,203 | €106,208 | ▲ 401% |
| Suppliers440/4 | €118 | €21,203 | €106,208 | ▲ 401% |
| Taxes, remuneration and social security45 | - | €3,723 | €12,816 | ▲ 244% |
| Taxes450/3 | - | €338 | €1,355 | ▲ 301% |
| Remuneration and social security454/9 | - | €3,385 | €11,460 | ▲ 239% |
| Other amounts payable47/48 | €316 | €4,316 | €28,337 | ▲ 557% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | -€11,042 | €7,065 | €22,651 | ▲ 221% |
| + Depreciation and write-downs630 | €1,108 | €5,787 | €13,618 | ▲ 135% |
| Operating cash flow (approximation) | -€9,934 | €12,853 | €36,268 | ▲ 182% |
| Investment in fixed assets (approximation) | - | -€20,250 | -€101,974 | ▼ 404% |
| Change in cash | - | €1,399 | -€6,993 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 2,157 companies had the same profile as NEXUMED has now. Two years later, 94.1% were still going and 3.0% had gone bankrupt.
- Micro
- 2 to 5 years old
- solvency under 10%
- a profit of 5% of the balance sheet or more
Another 0.1% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of NEXUMED itself: 0.7% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,157 companies, not a prediction for NEXUMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.